Aldena Therapeutics, a private biotech company pioneering siRNA- based therapies for dermatological indications, has chosen PCI Pharma Services (PCI) (https://pci.com/drug-development-manufacturing-services/pharmaceutical-manufacturing-services/sterile-manufacturing-services/?utm_source=News-Website&utm_medium=Press-Release&utm_campaign=Aldena-2023), a world-leading global contract development and manufacturing organization (CDMO) to formulate, package, and distribute ALD-102, an siRNA-based inv…
– 출처 : https://www.newswire.co.kr/newsRead.php?no=976800&sourceType=rss